NCT06856603 OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites Status RECRUITING Phase PHASE2
NCT06424210 The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1) Status COMPLETED Phase N/A
NCT05789771 Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia. Status COMPLETED Phase N/A
NCT05188911 Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial Status UNKNOWN Phase N/A
NCT04492735 The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies Status UNKNOWN Phase N/A
NCT03823989 Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients Status COMPLETED Phase PHASE1
NCT03705403 IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study Status TERMINATED Phase PHASE2
NCT03632005 Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery Status UNKNOWN Phase NA
NCT02856867 Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) Status WITHDRAWN Phase PHASE2
NCT02795819 Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer Status TERMINATED Phase PHASE1
NCT02628379 Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary Status COMPLETED Phase N/A
NCT02496832 A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo Status WITHDRAWN Phase NA
NCT02175654 Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab Status TERMINATED Phase PHASE2
NCT01875380 Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01861938 Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients Status WITHDRAWN Phase PHASE2/PHASE3